Sinocare Pays $290M For PTS Diagnostics, Expands Diabetes Business

Sinocare, a Chinese medtech specializing in the development and manufacture of biosensor technology, has inked a deal to acquire U.S.-based PTS Diagnostics and its portfolio of point-of-care (POC) biometric testing devices. The $290-million deal expands Sinocare’s global foothold in the diabetes management market.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news